Summit Therapeutics PLC (SMMT) — Free Cash Flow Generation Index
Summit Therapeutics PLC (SMMT) has a Free Cash Flow Generation Index of 1.00x as of December 2022. Free cash flow of $4.24 Million represents 1% of operating cash flow ($4.23 Million). Read Summit Therapeutics PLC total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Summit Therapeutics PLC Free Cash Flow Generation Index (2004–2016)
Historical FCF Generation Index trend for Summit Therapeutics PLC across 2 annual periods. Explore SMMT capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Summit Therapeutics PLC (2004–2016)
Year-by-year Free Cash Flow Generation Index for Summit Therapeutics PLC. For the full company profile including market capitalisation, see market value of Summit Therapeutics PLC.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.99x | $15.07 Million | $15.18 Million | $110.00K | ▼ -31.8% |
| 2004 | 1.46x | $43.30K | $29.74K | $13.18K | — |